Advancing Translation Inhibition as an ADC MOA: Potency and ICD From a Novel Payload
- Clarifying translation inhibition as the MOA of septacidin
- Design and optimization of linker-payload technology for septacidin analogues
- Demonstrating strong ICD and in vivo efficacy from proof of concept ADCs